Point-by-Point Radiofrequency Ablation Versus the Cryoballoon or a Novel Combined Approach: A Randomized Trial Comparing 3 Methods of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (The Cryo Versus RF Trial)

The CRYO Versus RF Trial Introduction Catheter ablation of paroxysmal AF using the Cryoballoon (CRYO) has yielded similar success rates to conventional wide encirclement using radiofrequency catheter ablation (RFCA), but randomized data are lacking. Pilot data suggested a high success rate with a co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular electrophysiology 2015-12, Vol.26 (12), p.1307-1314
Hauptverfasser: HUNTER, ROSS J., BAKER, VICTORIA, FINLAY, MALCOLM C., DUNCAN, EDWARD R., LOVELL, MATTHEW J., TAYEBJEE, MUZAHIR H., ULLAH, WAQAS, SIDDIQUI, M. SHOAIB, McLEAN, AILSA, RICHMOND, LAURA, KIRKBY, CLAIRE, GINKS, MATTHEW R., DHINOJA, MEHUL, SPORTON, SIMON, EARLEY, MARK J., SCHILLING, RICHARD J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The CRYO Versus RF Trial Introduction Catheter ablation of paroxysmal AF using the Cryoballoon (CRYO) has yielded similar success rates to conventional wide encirclement using radiofrequency catheter ablation (RFCA), but randomized data are lacking. Pilot data suggested a high success rate with a combined approach (COMBINED) using wide encirclement with RFCA followed by 2 CRYO applications to each vein. We compared these 3 strategies in a randomized controlled trial. Methods and Results Patients undergoing first time paroxysmal AF ablation were randomized to RFCA, CRYO, or COMBINED. Patients were followed up at 3, 6, and 12 months with 7 days of ambulatory ECG monitoring. Success was defined as freedom from arrhythmia without antiarrhythmic drugs after a single procedure. A total of 237 patients were randomized. Success at 1 year was achieved in 47% in the RFCA group, 67% in the CRYO group, and 76% in the COMBINED group (P < 0.001 for RFCA vs. CRYO, P
ISSN:1045-3873
1540-8167
DOI:10.1111/jce.12846